Omeros Corp OMER:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
3.15quote price arrow down-0.07 (-2.17%)
Volume
211,196
52 week range
1.85 - 13.89
Loading...
  • Open3.20
  • Day High3.30
  • Day Low3.15
  • Prev Close3.22
  • 52 Week High13.89
  • 52 Week High Date09/30/21
  • 52 Week Low1.85
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap197.60M
  • Shares Out62.73M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change-51.01

KEY STATS

  • Open3.20
  • Day High3.30
  • Day Low3.15
  • Prev Close3.22
  • 52 Week High13.89
  • 52 Week High Date09/30/21
  • 52 Week Low1.85
  • 52 Week Low Date06/16/22
  • Market Cap197.60M
  • Shares Out62.73M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change-51.01

RATIOS/PROFITABILITY

  • EPS (TTM)-3.00
  • P/E (TTM)-1.05
  • Fwd P/E (NTM)-1.61
  • EBITDA (TTM)-168.769M
  • ROE (TTM)-
  • Revenue (TTM)-21.06M
  • Gross Margin (TTM)98.89%
  • Net Margin (TTM)-136.61%
  • Debt To Equity (MRQ)-961.28%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Omeros Corp

 

Profile

MORE
Omeros Corporation is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic diseases, including complement-mediated diseases and cancers related to dysfunction of the immune system, as well as addictive and compulsive disorders. Its lead lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject...
Gregory Demopulos M.D.
Chairman of the Board, President, Chief Executive Officer
Michael Jacobsen
Vice President - Finance, Chief Accounting Officer, Treasurer
Bruce Meiklejohn Ph.D.
Vice President - Chemistry, Manufacturing and Controls
Peter Cancelmo J.D.
Vice President, General Counsel, Secretary
Tina Quinton J.D.
Vice President - Patents
Address
201 Elliott Avenue West
Seattle, WA
98119
United States

Top Peers

SYMBOLLASTCHG%CHG
HROW
Harrow Health Inc
12.07+0.55+4.77%
OPTN
OptiNose Inc
3.66+0.18+5.17%
PRTK
Paratek Pharmaceuticals Inc
2.57+0.06+2.39%
EYPT
EyePoint Pharmaceuticals Inc
7.91+0.52+7.04%
SCTL
Societal CDMO Inc
1.63UNCHUNCH